Quantitative analysis of retinal and brain Cp+ immunoreactive (IR, mAb) area revealed significant 2.9- and 4.1-fold increases in Cp inclusions, respectively, in AD patients compared with NC controls (Fig. 1E; p<0.0001). This evidence concerns the gene CP and Alzheimer disease.